7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Elders RC et al. | Susceptibility of the C2 canine mastocytoma cell line to the effects of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | 2009 | Vet. Immunol. Immunopathol. | pmid:19185923 |
Booij-Vrieling HE et al. | Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. | 2009 | Vet. Immunol. Immunopathol. | pmid:19556012 |
Gu JH et al. | Effects of RANKL, osteoprotegerin, calcium and phosphorus on survival and activation of Muscovy duck osteoclasts in vitro. | 2009 | Vet. J. | pmid:18682334 |
Ito R et al. | Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma. | 2003 | Virchows Arch. | pmid:12838418 |
Gibbons CL et al. | Osteoclast-like cells in soft tissue leiomyosarcomas. | 2010 | Virchows Arch. | pmid:20127110 |
Ito S and Hata T | Crystal structure of RANK ligand involved in bone metabolism. | 2004 | Vitam. Horm. | pmid:15110169 |
Hao C et al. | Modulation of TRAIL signaling complex. | 2004 | Vitam. Horm. | pmid:15110173 |
Ivanov SD et al. | [Prognosis of efficacy of organ-saving treatment of invasive bladder cancer]. | 2006 | Vopr Onkol | pmid:17168368 |
Gajewska J et al. | [The impairement of bone formation and resorption in 25-year-old man with neglected celiac disease]. | 2005 | Wiad. Lek. | pmid:16238129 |
Sobańska I et al. | [The influence of sex and age on the osteoprotegerin level in the blood]. | 2007 | Wiad. Lek. | pmid:17966895 |
Wagner D and Fahrleitner-Pammer A | Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help? | 2010 | Wien Med Wochenschr | pmid:20714810 |
Winzer M et al. | Glycitein decreases the generation of murine osteoclasts and increases apoptosis. | 2010 | Wien Med Wochenschr | pmid:20714813 |
Gruber R | Cell biology of osteoimmunology. | 2010 | Wien Med Wochenschr | pmid:20714814 |
Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
Beke D et al. | [Clinical relevance of biomarkers in cancer related bone disease]. | 2007 | Wien Med Wochenschr | pmid:17922085 |
Kerschan-Schindl K | Bone turnover in hyperparathyroidism. | 2013 | Wien Med Wochenschr | pmid:22805761 |
Fahrleitner-Pammer A et al. | Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. | 2003 | Wien. Klin. Wochenschr. | pmid:12793029 |
Fahrleitner A et al. | Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status. | 2002 | Wien. Klin. Wochenschr. | pmid:12602117 |
Sood SK et al. | Osteoprotegerin (OPG) and related proteins (RANK, RANKL and TRAIL) in thyroid disease. | 2011 | World J Surg | pmid:21748518 |
Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |